Physicians EZ Use M-pred
- Product NDC
- 63187-352
- 11-digit product format
- 631870352
- Labeler code
- 63187
- Product ID
- 63187-352_f23a3dc4-62e9-46d0-a4b7-383dd5e02911
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- METHYLPREDNISOLONE ACETATE, BUPIVACAINE HYDROCHLORIDE, POVIDONE-IODINE
- Dosage form
- KIT
- Labeler
- Proficient Rx LP
- Application
- NDA016964
- Marketing category
- NDA
- Marketing start
- 2013-05-30
- Marketing end
- 0000-00-00
- Active strength
- 0
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 63187-352 | I | Inactivated by FDA | 2026-10-05 | ||
| excluded package | package | 63187-352 | 63187-352-01 | I | Inactivated by FDA | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | I | Inactivated by FDA | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | I | Inactivated by FDA | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | I | Inactivated by FDA | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | I | Inactivated by FDA | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | I | Inactivated by FDA | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | I | Inactivated by FDA | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | I | Inactivated by FDA | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | I | Inactivated by FDA | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | I | Inactivated by FDA | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | 1332a3947898… | d4bfe170f9cd… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 63187-352-01 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded product | product | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… | |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 63187-352-01 | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N016964-001 | MARCAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N016964-004 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE | BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE | 0.25%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N016964-005 | MARCAINE HYDROCHLORIDE PRESERVATIVE FREE | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N016964-006 | MARCAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N016964-007 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE | 0.5%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N016964-008 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE | BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE | 0.5%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N016964-009 | MARCAINE HYDROCHLORIDE PRESERVATIVE FREE | BUPIVACAINE HYDROCHLORIDE | 0.75% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N016964-010 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE | 0.75%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N016964-012 | MARCAINE HYDROCHLORIDE PRESERVATIVE FREE | BUPIVACAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N016964-013 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE | 0.25%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N016964-001 | AP |
| N016964-004 | AP |
| N016964-005 | AP |
| N016964-006 | AP |
| N016964-007 | AP |
| N016964-008 | AP |
| N016964-009 | AP |
| N016964-010 | AP |
| N016964-012 | AP |
| N016964-013 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N016964-001 | MARCAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N016964-004 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE | 0.25%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N016964-005 | MARCAINE HYDROCHLORIDE PRESERVATIVE FREE | 0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N016964-006 | MARCAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N016964-007 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | 0.5%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N016964-008 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE | 0.5%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N016964-009 | MARCAINE HYDROCHLORIDE PRESERVATIVE FREE | 0.75% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N016964-010 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | 0.75%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N016964-012 | MARCAINE HYDROCHLORIDE PRESERVATIVE FREE | 0.25% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N016964-013 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | 0.25%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N016964-001 | MARCAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N016964-004 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE | 0.25%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N016964-005 | MARCAINE HYDROCHLORIDE PRESERVATIVE FREE | 0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N016964-006 | MARCAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N016964-007 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | 0.5%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N016964-008 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE | 0.5%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N016964-009 | MARCAINE HYDROCHLORIDE PRESERVATIVE FREE | 0.75% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N016964-010 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | 0.75%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N016964-012 | MARCAINE HYDROCHLORIDE PRESERVATIVE FREE | 0.25% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N016964-013 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | 0.25%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-001 | MARCAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-004 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE | 0.25%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-005 | MARCAINE HYDROCHLORIDE PRESERVATIVE FREE | 0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-006 | MARCAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-007 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | 0.5%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-008 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE | 0.5%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-009 | MARCAINE HYDROCHLORIDE PRESERVATIVE FREE | 0.75% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-010 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | 0.75%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-012 | MARCAINE HYDROCHLORIDE PRESERVATIVE FREE | 0.25% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-013 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | 0.25%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-001 | MARCAINE HYDROCHLORIDE | 0.25% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-004 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE | 0.25%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-005 | MARCAINE HYDROCHLORIDE PRESERVATIVE FREE | 0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-006 | MARCAINE HYDROCHLORIDE | 0.5% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-007 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | 0.5%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-008 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE | 0.5%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-009 | MARCAINE HYDROCHLORIDE PRESERVATIVE FREE | 0.75% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-010 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | 0.75%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-012 | MARCAINE HYDROCHLORIDE PRESERVATIVE FREE | 0.25% | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-013 | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | 0.25%;0.0091MG/ML | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N016964-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N016964-004 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N016964-005 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N016964-006 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N016964-007 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N016964-008 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N016964-009 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N016964-010 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N016964-012 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N016964-013 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N016964-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N016964-004 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N016964-005 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N016964-006 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N016964-007 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N016964-008 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N016964-009 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N016964-010 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N016964-012 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N016964-013 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-001 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-004 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-005 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-006 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-007 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-008 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-009 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-010 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-012 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N016964-013 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-001 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-004 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-005 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-006 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-007 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-008 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-009 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-010 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-012 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N016964-013 | AP | 1 | 31067a03dcf5… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63187-352-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-f62e-f424-e053-dadaa90a57ce | f23a3dc4-62e9-46d0-a4b7-383dd5e02911 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0703-0043-01 | Physicians EZ Use M-pred | 5 mL in 1 VIAL, MULTI-DOSE | INJECTION, SUSPENSION | 5 mL | 40 mg in 1mL | 1 |
| 63187-352-01 | Physicians EZ Use M-pred | 1 in 1 CARTON | KIT | 1 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63187-352-01 | EA - Each | 63187-352 | 1a81bf0e-b5d1-4d47-9b2b-2385d0a33b3b | 1 | 2015-10-02 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Marcaine | BUPIVACAINE HYDROCHLORIDE | Henry Schein, Inc. | 562f4499-f3b7-4d9e-b022-61172176c883 | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | 016964 NDA016964 |
| Marcaine | BUPIVACAINE HYDROCHLORIDE | Henry Schein, Inc. | 2c6f9b85-e783-4ad4-a804-a0ff1a32ec2c | 2026-06-24 | Warnings, Adverse reactions | 016964 NDA016964 |
| Marcaine | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 67578b56-7540-487e-1fba-481255620e78 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | 016964 NDA016964 |
| MARCAINE WITH EPINEPHRINE | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Henry Schein, Inc. | d0d51133-882c-4f9e-ba1c-f037226305a1 | 2026-01-28 | Boxed warning, Warnings, Adverse reactions | 016964 NDA016964 |
| Marcaine | BUPIVACINE HYDROCHLORIDE | Henry Schein, Inc. | 7d94e8e0-0d1e-4af3-973a-a480d7d51737 | 2026-01-26 | Warnings, Adverse reactions | 016964 NDA016964 |
| Marcaine with Epinephrine | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE | Hospira, Inc. | 93cf0914-de08-4ec6-8f8c-d663243b9958 | 2024-02-02 | Boxed warning, Warnings, Adverse reactions | 016964 NDA016964 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1724880 | BUPivacaine HCl 0.5 % in 10 ML Injection | PSN | f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | 1 |
| 1725044 | Marcaine 0.5 % in 10 ML Injection | PSN | f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | 1 |
| 1358610 | methylPREDNISolone acetate 40 MG/ML Injectable Suspension | PSN | f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | 1 |
| 797730 | povidone-iodine 10 % Medicated Pad | PSN | f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | 1 |
| 1725044 | 10 ML bupivacaine hydrochloride 5 MG/ML Injection [Marcaine] | SBD | f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | 1 |
| 1724880 | 10 ML bupivacaine hydrochloride 5 MG/ML Injection | SCD | f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | 1 |
| 1358610 | methylprednisolone acetate 40 MG/ML Injectable Suspension | SCD | f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | 1 |
| 797730 | povidone-iodine 100 MG/ML Medicated Pad | SCD | f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | 1 |
| 1725044 | 10 ML Marcaine 5 MG/ML Injection | SY | f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | 1 |
| 1724880 | bupivacaine HCl 0.5 % in 10 ML Injection | SY | f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | 1 |
| 1725044 | Marcaine 0.5 % in 10 ML Injection | SY | f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | 1 |
| 797730 | povidone-iodine 10 % (titratable iodine 1 % ) Medicated Pad | SY | f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | 1 |
| 797730 | povidone-iodine 10 % Medicated Pad | SY | f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | 1 |
| 797730 | povidone-iodine 10 % Medicated Swabstick | SY | f23a3dc4-62e9-46d0-a4b7-383dd5e02911 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Status |
|---|---|---|---|---|
| 0703-0043-01 | 00703004301 | 5 mL in 1 VIAL, MULTI-DOSE | 5 ml | Historical |
| 63187-352-01 | 63187035201 | 1 in 1 CARTON | Historical |